Skip to main content
aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
6.11
-0.10 (-1.69%)
At close: Nov 13, 2026, 4:00 PM EST
6.34
+0.24 (3.87%)
After-hours: Nov 13, 2026, 7:38 PM EST

aTyr Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.190.240.3510.39-
Revenue Growth
--19.15%-33.43%-96.60%--
Gross Profit
-60.22-60.03-54.14-41.94-32.42-23.26
Operating Income
-55.91-77.63-67.91-54.92-46.4-34.02
Net Income
-53.32-74.12-64.02-50.39-45.34-33.77
Earnings Per Share
-21.74-31.88-34.49-37.60-63.81-70.79
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
50.2578.6972.1398.1766.15107.91
Total Debt
10.9212.0313.2815.111.531.38
Net Cash (Debt)
39.3366.6558.8483.0754.61106.53
Net Cash Growth
-49.47%13.28%-29.17%52.11%-48.74%261.74%
Net Cash Per Share
16.0428.6731.6961.9976.87223.33

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--61.99-69.12-33.22-41.89-33.08
Capital Expenditures
--0.08-0.07-4.22-1.64-0.19
Free Cash Flow
--62.06-69.18-37.44-43.53-33.27
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
--40856.32%-28899.57%-15557.79%-446.79%-
Pretax Margin
--39012.11%-27243.40%-14276.77%-436.58%-
Profit Margin
--39009.47%-27243.83%-14274.50%-436.53%-
FCF Margin
--32664.74%-29440.00%-10605.10%-419.09%-

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-403.861293.07233.916.12-